M1228
HCPCSPt + hcv aby +vir w/ rx 3 mo
Official HCPCS Level II long descriptor
Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test
HCPCS Level II code M1228 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Pt + hcv aby +vir w/ rx 3 mo
Added to HCPCS: 2024-01-01
Nearby codes in M1
- M1220Dre wth interp rtnopthy
- M1221Dre w/o rtnopthy
- M1222Glaucoma pln of care not doc
- M1223Glaucoma plan of care doc
- M1224Iop dec <20% from base
- M1225Iop dec>=20% from base
- M1226Iop not doc
- M1227Eb therapy prescribed
- M1229Pt w/ +hcv +vir ref win 1 mo
- M1230Pt hcv rctv aby no f/u tst
- M1231Pt hcv tst no reactive res
- M1232Pt hcv tst reactive result
- M1233Pt no hcv aby or result
- M1234Pt hcv rctv aby f/u neg
- M1235Doc pt hcv aby rna tst
- M1236Baseline mrs > 2
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.